| |
The
best boards seek continuous improvement. Performance evaluations
can help guide individual directors and enhance what is
working well. Required by the exchanges for public companies
and touted as a best practice for all boards, why is there
such a range of opinions/emotions on the subject of board evaluations?
Panelists:
| John
Stiska - Chair, Corporate Directors
Forum; Principal, Regent Partners; former CEO, JNI |
|
| Karin
Eastham - COO Burnham Institute, Director,
Amylin, SGX Pharmaceuticals & Illumina |
| Terry
Vandewarker - Director, Isolagen; former
Director, Inamed |
| Scott
Stanton(Moderator) - Partner, National
Co-Chair for Public Companies, Morrison & Foerster |
This panel will provide a candid debate of the issues and concerns
on this subject and offer some strategies to assist you in developing
and implementing a system for your particular
organization.
-
Is there real value in doing board evaluations?
Says who?
-
Getting them done (and over with) vs. seeing
them as an opportunity
for refinement?
-
Who's doing them? With what results?
-
How
do I develop a meaningful evaluation for my particular
board?
-
What do I do with the information?
Is the
data an asset or a liability?
-
How should they be administered?
Open
to Members & Non-Members!
WHEN:
Tuesday, November 20, 2007
7:00a.m.-7:30a.m. – Coffee & Peer
Networking
7:30a.m.-9:00a.m. – Breakfast & Program
WHERE:
Hyatt Regency La Jolla
3777 La Jolla Village Drive
COST:
CDF Ind. Members - Free
CDF Corporate Members - Free (3)
Non-Members - $40.00
RSVP:
BY Friday, November 16, 2007
SPONSORED
BY:
 
|
|
|
|
